N-(6-(1-(2-((4-methyl-3-(trifluoromethyl)phenyl)amino)-2-oxoethyl)-1H-pyrazol-4-yl)-1H-indazol-3-yl)nicotinamide

ID: ALA4872941

PubChem CID: 164619493

Max Phase: Preclinical

Molecular Formula: C26H20F3N7O2

Molecular Weight: 519.49

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)Cn2cc(-c3ccc4c(NC(=O)c5cccnc5)n[nH]c4c3)cn2)cc1C(F)(F)F

Standard InChI:  InChI=1S/C26H20F3N7O2/c1-15-4-6-19(10-21(15)26(27,28)29)32-23(37)14-36-13-18(12-31-36)16-5-7-20-22(9-16)34-35-24(20)33-25(38)17-3-2-8-30-11-17/h2-13H,14H2,1H3,(H,32,37)(H2,33,34,35,38)

Standard InChI Key:  LNSYNFKGAXNAKD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
    3.7638  -12.0996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4734  -11.6901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4706  -10.8675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7620  -10.4622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0557  -11.6906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0569  -10.8741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2807  -10.6206    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7997  -11.2805    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2788  -11.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0251  -12.7185    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1768  -10.4562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9223  -10.7874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4668  -10.1781    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0555   -9.4719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2569   -9.6449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2799  -10.2604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6151  -11.0057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4281  -11.0881    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1372  -11.6686    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7633  -11.8334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2820  -12.4944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6165  -13.2391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4304  -13.3220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9086  -12.6541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5714  -11.9120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1384  -13.9018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3254  -13.8190    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.4732  -14.6472    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.5528  -14.4783    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.5710  -13.3266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3173  -14.1035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3706  -13.1579    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5164  -14.2676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2627  -15.0436    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8088  -15.6527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6120  -15.4805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8620  -14.7047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7666  -14.0668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  9 10  1  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 22 26  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
 10 30  1  0
 30 31  1  0
 30 32  2  0
 31 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 31  1  0
 23 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4872941

    ---

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HGC-27 (1452 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GES1 (603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 519.49Molecular Weight (Monoisotopic): 519.1631AlogP: 5.04#Rotatable Bonds: 6
Polar Surface Area: 117.59Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.95CX Basic pKa: 3.51CX LogP: 4.14CX LogD: 4.14
Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.29Np Likeness Score: -2.02

References

1. Wang XR, Wang S, Li WB, Xu KY, Qiao XP, Jing XL, Wang ZX, Yang CJ, Chen SW..  (2021)  Design, synthesis and biological evaluation of novel 2-(4-(1H-indazol-6-yl)-1H-pyrazol-1-yl)acetamide derivatives as potent VEGFR-2 inhibitors.,  213  [PMID:33493829] [10.1016/j.ejmech.2021.113192]

Source